Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-06-05 17:57:00 ET · period of report 2026-06-03 · accession 0001628280-26-041330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-05 17:57 | 2026-06-03 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $22.32 | -8,528 | 177.3K | -5% | -$190.3K |
| T | 2026-06-05 17:57 | 2026-06-04 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $22.27 | -10.3K | 167.1K | -6% | -$228.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-03 | F | D | 8,528 | $22.32 | 177,321 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |
| 2 | Common | Common Stock | 2026-06-04 | S | D | 10,259 | $22.27 | 167,062 | D | — | — | (F2) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on September 10, 2025. |